EncrypGen
Coconut Creek, Florida, United States
Founded in 2017, the company first demonstrated its prototype in May 2017 at the Bio-IT World conference in Boston. With angel investment and a limited token sale of its $DNA utility coin in June 2017, the product was finalized and launched, as announced in The Scientist magazine, November 6, 2018 as the world’s first blockchain-mediated free market for genetic data. Since then, its community of supporters and users has grown virally, and various partnerships and platform developments have poised the company for consumer growth. It remains the only free market for genomic data powered by blockchain, and is committed to democratizing and decentralizing science (De-Sci), allowing individuals to make choices and benefit monetarily through their contributions to research. To find out how we’re doing, take a look at our blog.
Only accessible to MedStartr community members.
Join nowCompany Info
- Founded
- 2018
- Website
- encrypgen.com
Only accessible to MedStartr community members.
Join nowWhat do you think of EncrypGen?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.
Only accessible to MedStartr community members.
Join now